0345 222 3550 Mental Health, Surgical & Ophthalmic, Palliative Care & Physical Rehabilitation
  • Home
  • About Us
  • Services
    • Medicines Management
    • Regulatory Compliance
    • Training
    • Product Supply
  • Resources
    • Live View
    • e-Works electronic prescribing
    • Health Awareness Resources
    • Clinical Guidelines
    • Choice & Medication
    • MaPPs (Medicines: A Patient Profile Summary)
    • NEWT Guidelines
    • Patient information leaflets
  • Order Online
  • Blog
    • Press Releases
  • Careers
  • Contact Us
    • Frequently Asked Questions
Improving quality and compliance in medicines management Improving quality and compliance in medicines management
  • Home
  • About Us
  • Services
    • Medicines Management
    • Regulatory Compliance
    • Training
    • Product Supply
  • Resources
    • Live View
    • e-Works electronic prescribing
    • Health Awareness Resources
    • Clinical Guidelines
    • Choice & Medication
    • MaPPs (Medicines: A Patient Profile Summary)
    • NEWT Guidelines
    • Patient information leaflets
  • Order Online
  • Blog
    • Press Releases
  • Careers
  • Contact Us
    • Frequently Asked Questions

New Product

Home / Ashtons News /
 Introducing our new Woolcool sustainable packaging!
0
By Darren Ellis
In Ashtons News, New Product, Simplifying Product Supply
Posted 1st March 2022

Introducing our new Woolcool sustainable packaging!

Woollen liners that are completely compostable and biodegradable! Made using natural and responsible materials, our new Woolcool thermal insulated mailing pouches help keep our products [...]

READ MORE
 Ashtons’ antipsychotic dosage and percentage calculator
0
By Dorna Ghashghaei
In Ashtons News, Developing your Team, New Product, Pharmacy Information, Training
Posted 23rd September 2021

Ashtons’ antipsychotic dosage and percentage calculator

Ashtons has recently produced a new handy antipsychotic dosage and percentage calculator. The guide offers an easy way to calculate the percentage BNF values of each antipsychotic. The chart is [...]

READ MORE
 Ashtons creates two respiratory clinical toolkits for COPD and Asthma
0
By Nabila Ditta
In Ashtons News, Conditions, Developing your Team, New Product, Training
Posted 22nd January 2021

Ashtons creates two respiratory clinical toolkits for COPD and Asthma

Asthma is a long-term condition characterised by paroxysmal and reversible obstruction of the airways, whereas Chronic Obstructive Pulmonary Disease (COPD) is a chronic, not fully reversible [...]

READ MORE
 High Dose Antipsychotic Treatment (HDAT)  – are you following the guidelines?
0
By Sara Skandarajah
In Ashtons News, Developing your Team, Mental Health, New Product, Training
Posted 7th January 2021

High Dose Antipsychotic Treatment (HDAT) – are you following the guidelines?

High Dose Antipsychotic Treatment (HDAT) is a term many of us are familiar with but are you confident in it’s use, need and subsequent monitoring requirements? Are the multidisciplinary team [...]

READ MORE
 Flu Vaccines for next winter 2021/2022 are now available for pre-order
0
By Shannen Stevens
In Ashtons News, Developing your Team, Mental Health, New Product, Training
Posted 4th January 2021

Flu Vaccines for next winter 2021/2022 are now available for pre-order

Advance planning for flu vaccination clinics has become an important part of patient care. The flu vaccination delivered in the following year provides vulnerable patients with protection against [...]

READ MORE
 Cariprazine (Reagila) – New antipsychotic from Recordati Pharmaceuticals Ltd
0
By Martin England
In Conditions, Feature article, Mental Health, New Product, Pharmacy Information
Posted 11th June 2019

Cariprazine (Reagila) – New antipsychotic from Recordati Pharmaceuticals Ltd

Cariprazine (Reagila) is a new second-generation antipsychotic which is licensed to treat schizophrenia in adults (over 18 years). It is only available as an oral capsule and is presented in [...]

READ MORE
 New formulation: clozapine (Zaponex) oral dispersible tablets
0
By Martin England
In New Product, Pharmacy Information
Posted 7th June 2019

New formulation: clozapine (Zaponex) oral dispersible tablets

A new formulation of clozapine will be available from June 2019 consisting of an oral dispersible tablet marketed as Zaponex orodispersible tablets by the company Leyden Delta BV. The special [...]

READ MORE
 Updated British Standard for first aid kits
0
By Shannen Stevens
In New Product, Simplifying Product Supply
Posted 7th June 2019

Updated British Standard for first aid kits

The British Standards Institute (BSI) has undertaken a review of the contents of first aid kits and updated them to a new British standard specification (BS 8599–1:2019). The standard has been [...]

READ MORE
 New drug: buprenorphine (Buvidal)  prolonged-release solution for injection
0
By Martin England
In New Product, Pharmacy Information
Posted 7th June 2019

New drug: buprenorphine (Buvidal) prolonged-release solution for injection

Buprenorphine has been long-established as an opioid substitution medication available as sublingual tablets. It is an opioid partial agonist/antagonist with strong receptor binding affinity and [...]

READ MORE
 New drug formulation – naloxone nasal spray
0
By Shannen Stevens
In New Product, Pharmacy Information
Posted 16th November 2018

New drug formulation – naloxone nasal spray

Nyxoid (naloxone nasal spray) is a novel formulation of naloxone, which is used for the emergency treatment of a patient who has a suspected opioid overdose. The single-use spray is administered [...]

READ MORE
1 2 3 4 5 6 7
page 1 of 7
Subscribe to Ashtons Pharmacy News

Follow us
Accreditations




What is this?

Resources
Online ordering
Ashtons Live View
MaPPs
Choice and medication
NEWT guidelines
Ashtons
Contact Us
Careers
FAQs
Terms & Conditions
Statutory Licences
Privacy Policy
Cookie Policy
COVID-19 Risk Assessment

Start typing and press Enter to search